Skip to main content
Key Specialties
Cardiology Diabetology Endocrinology Gastroenterology Geriatrics and Gerontology Gynecology and Obstetrics Hematology Infectious Disease Internal Medicine Nephrology Neurology Oncology Pediatrics Respiratory Medicine Rheumatology Surgery
Congress Coverage
2024 ACC Congress 2023 ESMO Congress 2023 EASD Congress 2023 ERS Congress 2023 ESC Congress
Clinical Collections
Advances in Alzheimer’s

At a glance: The STEP trials

A round-up of the STEP phase 3 clinical trials evaluating semaglutide for weight loss in people with overweight or obesity.
ADVANCED SEARCH
Log in
Top
Journal of General Internal Medicine
Published in: Journal of General Internal Medicine 11/2020

01-11-2020 | Telemedicine | Concise Research Report

Use of Direct-to-Consumer Telemedicine for Attention-Deficit Hyperactivity Disorder

Authors: Jessica A. Hohman, MD, MSc, MSc, Kathryn A. Martinez, PhD, MPH, Amit Anand, MD, Trejeeve Martyn, MD, Mark Rood, MD, Michael B. Rothberg, MD, MPH

Published in: Journal of General Internal Medicine | Issue 11/2020

Login to get access

Excerpt

Attention-deficit/hyperactivity disorder (ADHD) is increasingly prevalent.1, 2 Commonly a childhood-onset disorder, its symptoms frequently persist into adulthood.2 Untreated ADHD is associated with significant impairment, and there is growing unmet need for treatment—especially among adults.3 Although stimulants are the mainstay of pediatric therapy, management of ADHD in adults is less well-established, with studies suggesting roles for stimulants, non-stimulants, and therapy.1, 4 …
Literature
1.
Wilens TE, Faraone SV, Biederman J. Attention-deficit/hyperactivity disorder in adults. JAMA. 2004;292(5):619-23.PubMed
2.
Kooij SJ, Bejerot S, Blackwell A, Caci H, Casas-Brugue M, Carpentier PJ, et al. European consensus statement on diagnosis and treatment of adult ADHD: The European Network Adult ADHD. BMC Psychiatry. 2010;10:67.PubMedPubMedCentral
3.
Goodman DW, Surman CB, Scherer PB, Salinas GD, Brown JJ. Assessment of physician practices in adult attention-deficit/hyperactivity disorder. The primary care companion for CNS disorders. 2012;14(4):PCC.11m01312.
4.
Wilens TE. Drug therapy for adults with attention-deficit hyperactivity disorder. Drugs. 2003;63(22):2395-411.PubMed
5.
Singh SP, Tuomainen H. Transition from child to adult mental health services: needs, barriers, experiences and new models of care. World Psychiatry. 2015;14(3):358-61.PubMedPubMedCentral
Metadata
Title
Use of Direct-to-Consumer Telemedicine for Attention-Deficit Hyperactivity Disorder
Authors
Jessica A. Hohman, MD, MSc, MSc
Kathryn A. Martinez, PhD, MPH
Amit Anand, MD
Trejeeve Martyn, MD
Mark Rood, MD
Michael B. Rothberg, MD, MPH
Publication date
01-11-2020
Publisher
Springer International Publishing
Published in
Journal of General Internal Medicine / Issue 11/2020
Print ISSN: 0884-8734
Electronic ISSN: 1525-1497
DOI
https://doi.org/10.1007/s11606-020-05891-2

Other articles of this Issue 11/2020

Journal of General Internal Medicine 11/2020 Go to the issue

Original Research

Program Administrator Burnout in Graduate Medical Education: a Longitudinal Study

Healing Arts

Medical Students in the Time of COVID-19

Concise Research Report

How Influenza Vaccination Rate Variation Could Inform Pandemic-Era Vaccination Efforts

Original Research

Lifestyle Habits Associated with Weight Regain After Intentional Loss in Primary Care Patients Participating in a Randomized Trial

Letter to the Editor

Patient, Physician, and Environmental Predictors of Influenza Vaccination During Primary Care Visits

Original Research

Impact of the COVID-19 Pandemic on Healthcare Workers’ Risk of Infection and Outcomes in a Large, Integrated Health System
Obesity Clinical Trial Summary

At a glance: The STEP trials

Read more

A round-up of the STEP phase 3 clinical trials evaluating semaglutide for weight loss in people with overweight or obesity.

Developed by: Springer Medicine

Highlights from the ACC 2024 Congress

Year in Review: Pediatric cardiology

Pediatric Cardiology Video

Watch Dr. Anne Marie Valente present the last year's highlights in pediatric and congenital heart disease in the official ACC.24 Year in Review session.

Year in Review: Pulmonary vascular disease

Cardiopulmonary Comorbidity Video

The last year's highlights in pulmonary vascular disease are presented by Dr. Jane Leopold in this official video from ACC.24.

Year in Review: Valvular heart disease

Valvular Heart Disease Video

Watch Prof. William Zoghbi present the last year's highlights in valvular heart disease from the official ACC.24 Year in Review session.

Year in Review: Heart failure and cardiomyopathies

Heart Failure Video

Watch this official video from ACC.24. Dr. Biykem Bozkurt discuss last year's major advances in heart failure and cardiomyopathies.

ACC 2024 Congress Coverage

Heart Failure Video

Year in Review: Heart failure and cardiomyopathies

Watch now

Watch this official video from ACC.24. Dr. Biykem Bozkurt discuss last year's major advances in heart failure and cardiomyopathies.

Semaglutide benefits people with type 2 diabetes and obesity-related heart failure

16-04-2024 Type 2 Diabetes News

Incentivised to exercise

11-04-2024 Lifestyle Modifications News

New intervention for STEMI-related cardiogenic shock

10-04-2024 Myocardial Infarction News

» View more highlights on the ACC 2024 congress hub page

Image Credits